Philogen SpA (PHIL) Price & Analysis

Compare

10 Followers

PHIL Stock Chart & Stats

€24.20

-€0.15(-0.79%)

At close: Jan 08 4:00 PM EST

€24.20

-€0.15(-0.79%)

Day’s Range― - ―

52-Week Range€16.50 - €27.80

Previous CloseN/A

Volume5.57K

Average Volume (3M)19.28K

Market Cap

€719.37M

Enterprise Value€772.99M

Total Cash (Recent Filing)€100.02M

Total Debt (Recent Filing)€11.50M

Price to Earnings (P/E)21.6

Beta-0.09

Next Earnings

Nov 11, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding29,242,860

10 Day Avg. Volume19,753

30 Day Avg. Volume19,281

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)5.67

Price to Sales (P/S)10.62

P/FCF Ratio20.32

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€25.00

Price Target Upside3.31% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Financial GrowthPhilogen anticipates tripling its revenues through its partnership agreement with Sun Pharma, indicating strong financial growth prospects.

Licensing AgreementPhilogen's global licensing agreement with RayzeBio for OncoACP3 boosts investor confidence in its innovation capabilities beyond existing products.

Bears Say

Market PerceptionAnalyst views Philogen's late-stage pipeline as underappreciated by the market, suggesting potential undervaluation of its stock.

Philogen SpA News

Philogen S.p.A. Updates Share Buyback Program

An update from Philogen SpA ( ($IT:PHIL) ) is now available. Philogen S.p.A. has announced an update on...

29d ago

Philogen S.p.A. Updates on Share Buyback Program

Philogen SpA ( ($IT:PHIL) ) has issued an update. Philogen S.p.A. announced an update on its share buyback...

1M ago

Philogen Updates on Share Buyback Program

Philogen SpA ( ($IT:PHIL) ) just unveiled an announcement. Philogen S.p.A. announced an update on its share buyback...

1M ago

Philogen Reports Strong Revenue Growth and Advances in Clinical Pipeline

An announcement from Philogen SpA ( ($IT:PHIL) ) is now available. Philogen S.p.A. reported its half-year financial results...

2M ago

Philogen S.p.A. Updates on Share Buyback Program

The latest update is out from Philogen SpA ( ($IT:PHIL) ). Philogen S.p.A. has announced an update on...

2M ago

Philogen Finalizes $1.35 Billion OncoACP3 License Agreement with RayzeBio

Philogen SpA ( ($IT:PHIL) ) has provided an announcement. Philogen S.p.A. announced that its subsidiary, Philochem AG, has...

3M ago

Philogen Updates Share Buyback Program with Recent Purchases

An update from Philogen SpA ( ($IT:PHIL) ) is now available. Philogen S.p.A. announced an update on its...

4M ago

Philogen Updates Share Buyback Program with Recent Purchases

Philogen SpA ( ($IT:PHIL) ) has shared an update. Philogen S.p.A. has announced an update on its share...

4M ago

Philogen Withdraws Nidlegy™ Application from EMA, Plans Resubmission

Philogen SpA ( ($IT:PHIL) ) just unveiled an update. Philogen has decided to withdraw its marketing authorization application...

5M ago

Philochem Licenses Prostate Cancer Agent to RayzeBio in $1.35 Billion Deal

An announcement from Philogen SpA ( ($IT:PHIL) ) is now available. Philogen’s subsidiary, Philochem AG, has licensed the...

5M ago

PHIL FAQ

What was Philogen SpA’s price range in the past 12 months?

Philogen SpA lowest stock price was €16.50 and its highest was €27.80 in the past 12 months.

What is Philogen SpA’s market cap?

Philogen SpA’s market cap is €719.37M.

When is Philogen SpA’s upcoming earnings report date?

Philogen SpA’s upcoming earnings report date is Nov 11, 2025 which is today.

How were Philogen SpA’s earnings last quarter?

Currently, no data Available

Is Philogen SpA overvalued?

According to Wall Street analysts Philogen SpA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Philogen SpA pay dividends?

Philogen SpA does not currently pay dividends.

What is Philogen SpA’s EPS estimate?

Philogen SpA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Philogen SpA have?

Philogen SpA has 29,242,860 shares outstanding.

What happened to Philogen SpA’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Philogen SpA?

Currently, no hedge funds are holding shares in IT:PHIL

Company Description

Philogen SpA

Philogen SpA (PHIL) is an innovative biotechnology company based in Italy, specializing in the development of targeted therapies for cancer and other serious diseases. The company focuses on the discovery and production of proprietary monoclonal antibodies and small molecules that are designed to selectively bind to tumor cells and deliver therapeutic agents more effectively. Philogen operates primarily in the biopharmaceutical sector and is dedicated to advancing its pipeline of drug candidates through clinical trials and collaborations.

Philogen SpA (PHIL) Earnings & Revenues

Historic Earnings Reports

PHIL Stock 12 Month Forecast

Average Price Target

€25.00

▲(3.31% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"€16","21":"€21","26":"€26","18.5":"€18.5","23.5":"€23.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€25.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€25.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,18.5,21,23.5,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Feb<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.6,23.70769230769231,23.815384615384616,23.923076923076923,24.03076923076923,24.138461538461538,24.246153846153845,24.353846153846156,24.461538461538463,24.56923076923077,24.676923076923078,24.784615384615385,24.892307692307693,{"y":25,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.6,23.70769230769231,23.815384615384616,23.923076923076923,24.03076923076923,24.138461538461538,24.246153846153845,24.353846153846156,24.461538461538463,24.56923076923077,24.676923076923078,24.784615384615385,24.892307692307693,{"y":25,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,23.6,23.70769230769231,23.815384615384616,23.923076923076923,24.03076923076923,24.138461538461538,24.246153846153845,24.353846153846156,24.461538461538463,24.56923076923077,24.676923076923078,24.784615384615385,24.892307692307693,{"y":25,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":18.05,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.2,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.2,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.55,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.95,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.25,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.85,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.5,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.6,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >